Analyst Ratings For NASDAQ:AMAG – AMAG Pharmaceuticals (NASDAQ:AMAG)
Today, NASDAQ:AMAG – AMAG Pharmaceuticals (NASDAQ:AMAG) stock was downgraded by Janney Montgomery Scott from Buy ➝ Neutral to .
Some recent analyst ratings include
- 6/15/2018-Janney Montgomery Scott was Downgraded by analysts at Janney Montgomery Scott from a “Buy ➝ Neutral” rating to a “” rating.
- 5/21/2018-Leerink Swann initiated coverage with a Market Perform rating.
- 3/5/2018-Jefferies Financial Group was Downgraded by analysts at Jefferies Financial Group from a “Buy ➝ Hold” rating to a “” rating. They now have a $21.00 ➝ $20.00 price target on the stock.
- 3/1/2018-Piper Jaffray Companies Reiterated Rating of Hold.
- 2/27/2018-Cowen Reiterated Rating of Hold.
- On 6/4/2018 William K Heiden, CEO, sold 20,000 with an average share price of $25.00 per share and the total transaction amounting to $500,000.00.
- On 3/6/2018 Joseph Vittiglio, EVP, sold 770 with an average share price of $20.80 per share and the total transaction amounting to $16,016.00.
- On 8/29/2017 Joseph Vittiglio, SVP, sold 1,250 with an average share price of $16.75 per share and the total transaction amounting to $20,937.50.
- On 7/13/2017 Julie Krop, SVP, sold 4,938 with an average share price of $20.00 per share and the total transaction amounting to $98,760.00.
- On 5/1/2017 Julie Krop, SVP, sold 1,891 with an average share price of $24.45 per share and the total transaction amounting to $46,234.95.
- On 10/20/2016 Julie Krop, SVP, sold 4,938 with an average share price of $24.80 per share and the total transaction amounting to $122,462.40.
- On 11/10/2015 John A Fallon, Director, bought 3,230 with an average share price of $31.20 per share and the total transaction amounting to $100,776.00.
Recent Trading Activity for NASDAQ:AMAG – AMAG Pharmaceuticals (NASDAQ:AMAG)
Shares of NASDAQ:AMAG – AMAG Pharmaceuticals closed the previous trading session at 22.90 down -1.85 7.47% with 24.450000762939453 shares trading hands.